Replies to post #207839 on Biotech Values

[DewDiligence]

ENTA—...were the CERTAIN-1 study results released earlier than expected?

The original listing for the trial in clinicaltrials.gov showed primary-endpoint completion in May 2017, but at some point it was moved up to Dec 2016. So, the results from the 8-week TN/GT1 arm in yesterday's PR came out earlier than originally expected. Note, however, that ABBV/ENTA have not yet reported data from the 12-week arm for all genotypes or from the arm limited to renally-impaired patients.